We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITRI icon
1576
Itron
ITRI
$3.73B
-12,709
Closed -$593K
IVW icon
1577
iShares S&P 500 Growth ETF
IVW
$72.5B
-8,416
Closed -$363K
IWM icon
1578
iShares Russell 2000 ETF
IWM
$80.9B
-12,547
Closed -$1.93M
IYC icon
1579
iShares US Consumer Discretionary ETF
IYC
$1.12B
-5,776
Closed -$295K
IYE icon
1580
iShares US Energy ETF
IYE
$1.74B
-2,733
Closed -$98K
JAZZ icon
1581
Jazz Pharmaceuticals
JAZZ
$15.9B
-14,363
Closed -$2.05M
JD icon
1582
JD.com
JD
$40.8B
-454,984
Closed -$13.7M
JELD icon
1583
JELD-WEN Holding
JELD
$94.8M
-8,090
Closed -$143K
JHG
1584
DELISTED
Janus Henderson
JHG
-3,183
Closed -$80K
JKHY icon
1585
Jack Henry & Associates
JKHY
$10.7B
-27,186
Closed -$3.77M
JLL icon
1586
Jones Lang LaSalle
JLL
$15.1B
-81,569
Closed -$12.6M
JNJ icon
1587
Johnson & Johnson
JNJ
$635B
-105,502
Closed -$14.7M
JNPR
1588
DELISTED
Juniper Networks
JNPR
-79
Closed -$2K
JOE icon
1589
St. Joe Company
JOE
$3.57B
-135,762
Closed -$2.24M
JOUT icon
1590
Johnson Outdoors
JOUT
$482M
-70,157
Closed -$5.01M
JRVR icon
1591
James River Group Holdings
JRVR
$218M
-24,137
Closed -$967K
JWN
1592
DELISTED
Nordstrom
JWN
-33,557
Closed -$1.49M
KAI icon
1593
Kadant
KAI
$3.69B
-32,687
Closed -$2.88M
KALA icon
1594
KALA BIO
KALA
$11.8M
-16
Closed -$325K
KALV
1595
DELISTED
KalVista Pharmaceuticals
KALV
-29,452
Closed -$843K
KB icon
1596
KB Financial Group
KB
$41.2B
-931
Closed -$34K
KBE icon
1597
State Street SPDR S&P Bank ETF
KBE
$1.64B
-5,315
Closed -$222K
KBWB icon
1598
Invesco KBW Bank ETF
KBWB
$7.08B
-2,924
Closed -$141K
KEN icon
1599
Kenon Holdings
KEN
$3.61B
-5,565
Closed -$1K
KEY icon
1600
KeyCorp
KEY
$24.3B
-15,615
Closed -$246K

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.